Novel Allosteric Modulators of G Protein-coupled Receptors

被引:157
作者
Gentry, Patrick R. [1 ]
Sexton, Patrick M. [1 ]
Christopoulos, Arthur [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
MUSCARINIC ACETYLCHOLINE-RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; IMPROVES GLYCEMIC CONTROL; DRUG DISCOVERY; BINDING-SITE; STRUCTURAL BASIS; IN-VIVO; FUNCTIONAL SELECTIVITY; MONOCLONAL-ANTIBODY; SIGNALING PATHWAYS;
D O I
10.1074/jbc.R115.662759
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topographically distinct, yet conformationally linked, domains. Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chemical probes due to the potential for novel therapeutics. It is now apparent that some GPCRs possess more than one targetable allosteric site, in addition to a growing list of putative endogenous modulators. Advances in structural biology are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biological characterization.
引用
收藏
页码:19478 / 19488
页数:11
相关论文
共 98 条
[1]   A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design [J].
Acher, Francine C. ;
Selvam, Chelliah ;
Pin, Jean-Philippe ;
Goudet, Cyril ;
Bertrand, Hugues-Olivier .
NEUROPHARMACOLOGY, 2011, 60 (01) :102-107
[2]   An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5 [J].
Andrews, Glen ;
Jones, Carolyn ;
Wreggett, Keith A. .
MOLECULAR PHARMACOLOGY, 2008, 73 (03) :855-867
[3]   XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity [J].
Bhaskar, V. ;
Lau, A. ;
Goldfine, I. D. ;
Narasimha, A. J. ;
Gross, L. M. ;
Wong, S. ;
Cheung, B. ;
White, M. L. ;
Corbin, J. A. .
DIABETES OBESITY & METABOLISM, 2013, 15 (03) :272-275
[4]   A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control [J].
Bhaskar, Vinay ;
Goldfine, Ira D. ;
Bedinger, Daniel H. ;
Lau, Angela ;
Kuan, Hua F. ;
Gross, Lisa M. ;
Handa, Masahisa ;
Maddux, Betty A. ;
Watson, Susan R. ;
Zhu, Shirley ;
Narasimha, Ajay J. ;
Levy, Raphael ;
Webster, Lynn ;
Wijesuriya, Sujeewa D. ;
Liu, Naichi ;
Wu, Xiaorong ;
Chemla-Vogel, David ;
Catarina Tran ;
Lee, Steve R. ;
Wong, Steve ;
Wilcock, Diane ;
White, Mark L. ;
Corbin, John A. .
DIABETES, 2012, 61 (05) :1263-1271
[5]   Structure of Class B GPCRs: new horizons for drug discovery [J].
Bortolato, Andrea ;
Dore, Andrew S. ;
Hollenstein, Kaspar ;
Tehan, Benjamin G. ;
Mason, Jonathan S. ;
Marshall, Fiona H. .
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (13) :3132-3145
[6]   BRET analysis of GPCR oligomerization: newer does not mean better [J].
Bouvier, Michel ;
Heveker, Nikolaus ;
Jockers, Ralf ;
Marullo, Stefano ;
Milligan, Graeme .
NATURE METHODS, 2007, 4 (01) :3-4
[7]   Allostery in GPCRs: 'MWC' revisited [J].
Canals, Meritxell ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
TRENDS IN BIOCHEMICAL SCIENCES, 2011, 36 (12) :663-672
[8]   Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia [J].
Chan, W. Y. ;
McKinzie, D. L. ;
Bose, S. ;
Mitchell, S. N. ;
Witkin, J. M. ;
Thompson, R. C. ;
Christopoulos, A. ;
Lazareno, S. ;
Birdsall, N. J. M. ;
Bymaster, F. P. ;
Felder, C. C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (31) :10978-10983
[9]   A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice [J].
Chen, Desu ;
Liao, Jiayu ;
Li, Na ;
Zhou, Caihong ;
Liu, Qing ;
Wang, Guangxing ;
Zhang, Rui ;
Zhang, Song ;
Lin, Lilin ;
Chen, Kaixian ;
Xie, Xin ;
Nan, Fajun ;
Young, Andrew A. ;
Wang, Ming-Wei .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) :943-948
[10]   N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors [J].
Chen, Yelin ;
Goudet, Cyril ;
Pin, Jean-Philippe ;
Conn, P. Jeffrey .
MOLECULAR PHARMACOLOGY, 2008, 73 (03) :909-918